Tag: Side Effects
Inhibition of Sclerostin May Increase Cardiovascular Risk
SOST genetic variants linked to lower risk for fracture and osteoporosis but higher risk for MI, major CV AEs
Small Increase Seen in Risk for Subdeltoid Bursitis With Flu Shot
Attributable risk was 7.78 additional cases of subdeltoid bursitis per million persons vaccinated
Hydroxychloroquine in COVID-19 Ups Risk for QTc Prolongation
Concurrent treatment with azithromycin linked to greater changes in corrected QT interval
Anticholinergic Burden Tied to Adverse Effects in Middle Age
Identification of at-risk populations varies by scale used, which could impact clinical practice
FDA: Singulair to Get ‘Black Box’ Warning
Drug has long carried warning of potentially dangerous neuropsychiatric side effects
Long-Term Antidepressant Use Appears to Raise Risk for T2DM
Study suggests glucose tolerance improves with antidepressant discontinuation or dose reduction
HbA1c Levels Lower in Older, Multimorbid Patients With T2DM
Patients with higher comorbidity burden more likely to be treated with insulin for T2DM
Obesity May Up Cardiotoxicity Risk From Breast Cancer Therapy
Obesity independently associated with treatment-related cardiotoxicity in breast cancer patients
SAE Rate Higher With Nilotinib Versus Placebo in Parkinson Disease
Exploratory biomarkers altered in response to nilotinib, including drop in hyperphosphorylated tau
Results Mixed for Twice-Daily APBI in Early Breast Cancer
APBI noninferior to WBI for preventing recurrence but linked to increased late toxicity, adverse cosmesis
